texas oncology more breakthroughs. more victories
Some of our cancer centers may have important notifications found on the location page. View More Important Notifications x

Christopher J. LaFargue, M.D., M.S., FACOG

Christopher J. LaFargue, M.D., M.S., FACOG Photo

Provider Type: Physician

Board Certifications:
  • Gynecologic Oncology
  • Obstetrics and Gynecology



  • Fellowship in Gynecologic Oncology
    The University of Texas MD Anderson Cancer Center, Houston, TX (2017 – 2021)
  • Master of Science, Cancer Biology
    The University of Texas Health Science Center at Houston, Graduate School of Biomedical Sciences, Houston, TX (2019)
  • Residency in Obstetrics and Gynecology
    University of California, Irvine Medical Center, Orange, CA (2013 – 2017)
  • Medical Doctorate
    New York Medical College, Valhalla, NY (2013)

Accolades & Memberships

  • American Congress of Obstetrics and Gynecology
  • American Society of Clinical Oncology
  • Society of Gynecologic Oncology
  • The University of Texas MD Anderson Cancer Center, Diane Denson Tobola Fellowship Award in Ovarian Cancer Research, Houston, TX (2020)
  • The University of Texas MD Anderson Cancer Center, Service to Education Award, Houston, TX (2019)
  • The University of Texas MD Anderson Cancer Center, Linda K. Manning Fellowship Award in Ovarian Cancer Research, Houston, TX (2018, 2019)

Surgery Locations

  • Baylor Scott & White All Saints Medical Center – Fort Worth
  • Baylor Scott & White Surgicare Fort Worth
  • Texas Health Harris Methodist Hospital Fort Worth


Dr. LaFargue is a highly trained specialist with additional medical education in surgery, chemotherapy and radiation for the treatment of cervical, endometrial or uterine, ovarian, vulvar, and vaginal cancers.


  • Laparoscopic/ Davinci Robot
    • Davinci/robotic total hysterectomy bilateral salpingo-oophorectomy
    • Davinci/robotic bilateral salpingo-oophorectomy or cystectomy
    • Davinci/robotic resection of pelvic mass
    • Ovarian cancer primary or interval debulking/resection, staging
    • Sentinel node mapping, pelvic, retroperitoneal, para aortic lymphadenectomy 
  • Laparotomy/ Open Approach
    • Total abdominal hysterectomy bilateral salpingo-oophorectomy
    • Radical hysterectomy bilateral salpingo-oophorectomy, lymphadenectomy
    • Exploratory laparotomy
    • Laparotomy resection and or open excision of pelvic mass/malignancy, omentectomy, staging
    • Excision of vaginal mass
    • D&C with or without hysteroscopy
    • Colposcopy
    • Cold knife cone
    • Smit sleeve placement for brachytherapy
    • Laser of cervix, vulva and vagina
    • Full or partial vaginectomy
    • Simple partial or complete vulvectomy
    • Radical partial or complete vulvectomy with inguinal lymphadenectomy and sentinel node mapping
    • Wide local excision of vulvar mass

Research Interest

Dr. LaFargue has authored and co-authored numerous articles in peer reviewed journals. In addition to providing excellent clinical care, he continues to pursue his research interests which include the surgical and medical management of ovarian cancer, as well as the importance of clinical trials in gynecologic malignancies.

Dr. LaFargue is actively involved in the most current phase I through phase III clinical trials through the US Oncology research network.

Other Information

Dr. LaFargue provides cancer care with an emphasis on excellence, compassion, and understanding. He believes in working closely with the patient and the referring physician in order to provide quality care through a comprehensive, multidisciplinary approach. He is married with three children and enjoys playing guitar and attending live music shows.